Kidney Diseases: all 3,842 studies
Page 32 of 39. Open to participants first (491), then studies with results posted, then the rest; newest registration first within each.
- New Needle for Two-Needle HemodialysisStatus unknownNCT01416896Phase 2/3
- Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease (CKD)Status unknownNCT01415570
- The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young SubjectsCompletedNCT01414088Not applicable
- Cocoa Flavanols in Renal DiseaseCompletedNCT01412320Phase 1/2
- The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft BypassStatus unknownNCT01410617Phase 2/3
- Evaluation of Fructose Ingestion and the Renin Angiotensin System in HumansCompletedNCT01407627Not applicable
- Comparison of Markers of Kidney FunctionCompletedNCT01403766
- Web-based Interactive Health Communication Application (IHCA) for Successful Home DialysisStatus unknownNCT01403454Not applicable
- REduction of rIsk for Contrast Induced NephropathyStatus unknownNCT01402232
- PREdictive Value of COntrast voluMe to creatinINe Clearance RatioCompletedNCT01400295
- A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With NephropathyCompletedNCT01399580Phase 2
- Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) PatientsCompletedNCT01399489Not applicable
- Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary InterventionStatus unknownNCT01399203
- Pentraxin-3 in Chronic Renal FailureCompletedNCT01397773
- Steroids and Azathioprine in Advanced IgANCompletedNCT01392833Phase 3
- Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast AgentWithdrawnNCT01391520Phase 3
- Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis PatientsStatus unknownNCT01382966
- Prediction of Chronic Allograft NephropathyCompletedNCT01380847
- Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)CompletedNCT01380717Phase 4
- Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior ChangesCompletedNCT01377688
- Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)Status unknownNCT01377285Phase 4
- Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal InsufficiencyCompletedNCT01377246Phase 3
- Depressed Cardiac Autonomic Modulation in Patients With Chronic Kidney Disease Diagnosed by Spectral AnalysisCompletedNCT01376635
- Urine Adiponectin Concentration in Prediction of Contrast Induced NephropathyStatus unknownNCT01372891
- Impact of c242T Polymorphism of p22phox in Diabetic type1 NephropathyCompletedNCT01371955
- Mechanisms and Treatment of Intradialytic Hypertension - SodiumCompletedNCT01371890
- Prevalence of Aspirin Resistance in Chronic Kidney Disease PatientsCompletedNCT01364779
- Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney DiseaseStatus unknownNCT01364688Phase 2
- Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney DiseaseCompletedNCT01363336
- Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus RestrictionStatus unknownNCT01357317Phase 3
- Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) InhibitorCompletedNCT01356849Phase 2
- Weight Loss Improves Renal HemodynamicsCompletedNCT01356394Phase 4
- More Frequent In-Center Hemodialysis in Pediatric End Stage Renal DiseaseCompletedNCT01352455Not applicable
- Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 DiabetesTerminatedNCT01351675Phase 3
- Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis PatientsCompletedNCT01351636Phase 4
- Pulmonary Hypertension Prevention in HemodialysisStatus unknownNCT01350687
- Efficacy Study of Water Drinking on PKD Progression.CompletedNCT01348035
- BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney DiseaseCompletedNCT01345656Phase 2
- Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 SubjectsWithdrawnNCT01343641Phase 2
- Trial of an Internet-based Platform for Managing Chronic Diseases at a DistanceCompletedNCT01342263Not applicable
- Phosphate Binding of Chitosan Chewing Gum in Patients With Chronic Kidney Disease (CKD)CompletedNCT01341691Early Phase 1
- Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney DiseaseCompletedNCT01341678Not applicable
- Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaCompletedNCT01339975
- Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant RecipientsCompletedNCT01334333Phase 4
- FFT, Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease (CKD).Status unknownNCT01332526
- A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal FunctionCompletedNCT01331941Phase 1
- Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic NephropathyCompletedNCT01331317Phase 4
- Influence of Routinely Adding Ultrasound Screening in Medical DepartmentCompletedNCT01331187Not applicable
- Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney DiseaseCompletedNCT01328470Phase 4
- Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth HormoneCompletedNCT01327924
- Vitamin D Effect on Calcium Absorption on Persons on HemodialysisCompletedNCT01325610Not applicable
- Pomegranate Supplementation on Physical Function and Cardiovascular Disease Risk in CKD PatientsCompletedNCT01324193Not applicable
- Vitamin D Supplementation and Cardiac Hypertrophy in Chronic Kidney Disease (CKD)Status unknownNCT01323712Phase 2/3
- PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing GumCompletedNCT01319578Not applicable
- HepZero:Heparin Free Dialysis With EvodialCompletedNCT01318486Not applicable
- The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney DiseaseStatus unknownNCT01317186
- Factors Related to the Progression of Chronic Kidney DiseaseStatus unknownNCT01317173
- Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic PatientsStatus unknownNCT01316068Phase 4
- Salivary Phosphorus and Level of Kidney FunctionCompletedNCT01311973
- An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease in Pre-Dialysis or DialysisCompletedNCT01309295
- Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney DiseaseCompletedNCT01308242Early Phase 1
- Flavonoids in the Treatment of Endothelial Dysfunction in Children With DiabetesWithdrawnNCT01307917Not applicable
- A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney DiseaseCompletedNCT01305824Phase 2
- Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis PatientsCompletedNCT01305317Not applicable
- Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) PatientsWithdrawnNCT01302236Phase 4
- Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic NephropathyStatus unknownNCT01300273Phase 4
- The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) PatientsStatus unknownNCT01298869
- Patient INformation About Options for Treatment - PINOTCompletedNCT01298115
- Mechanisms of Infertility and Hormonal Changes in Patients With Chronic Kidney DiseaseWithdrawnNCT01294904
- Serum Magnesium and Vascular CalcificationCompletedNCT01293786
- Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced NephropathyCompletedNCT01292317Not applicable
- Nebivolol Versus Sustained Release Metoprolol Succinate in Patients With Chronic Kidney DiseaseCompletedNCT01291888
- Myocardial Microvascular Disease in ESRDTerminatedNCT01291771Not applicable
- Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney DiseaseCompletedNCT01282762
- Aortic Stiffness in Chronic Kidney Disease Stage 2 to 4CompletedNCT01279460
- Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4TerminatedNCT01277497Phase 4
- An Investigation on the Effect of Candesartan on Early Diabetic NephropathyStatus unknownNCT01273675
- An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)CompletedNCT01269021Not applicable
- Enhancing Education Regarding Living Donor Transplant Among Kidney Transplant CandidatesCompletedNCT01261910Not applicable
- Atorvastatin and Sympathetic Activity in Chronic Kidney DiseaseCompletedNCT01257009Phase 4
- An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac SurgeryCompletedNCT01256372Phase 2
- A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic NephropathyCompletedNCT01252056Phase 4
- Effect of N-acetylcysteine on Renal Functioning of Chronic Kidney Diseases(CKD) Patients After General AnesthesiaStatus unknownNCT01251029Phase 1
- Establish the Caring Model of Children With Chronic Kidney Disease and End-stage Renal Disease: To Set up Childhood Glomerular Filtration Rate (GFR) Formula in TaiwanStatus unknownNCT01250626
- Acute Effects of Cinacalcet on Arterial Stiffness and Ventricular Function in Hemodialysis PatientsCompletedNCT01250405Phase 4
- Vitamin D and the Health of Blood Vessels in Kidney DiseaseCompletedNCT01247311Not applicable
- Comparison of a Non-Invasive Central Venous Pressure Device and Physical Examination in Patients With Chronic Kidney DiseaseWithdrawnNCT01243515
- A Study to Evaluate the Effect of Renal Function on the Biological Activity of TelavancinCompletedNCT01238796Phase 1
- Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System BlockersCompletedNCT01237028Not applicable
- A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic PatientsStatus unknownNCT01236820
- Impact of Hemo-dialysis Therapy on Blood Levels of Treprostenil in End Stage Renal Disease Patients With Pulmonary HypertensionStatus unknownNCT01234571
- Intra Hemodialytic Oral Protein and Exercise (IHOPE)CompletedNCT01234441Not applicable
- Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)CompletedNCT01232257Phase 3
- Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male PatientsCompletedNCT01232010Phase 1
- Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male PatientsCompletedNCT01231997Phase 1
- Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal DialysisCompletedNCT01228279Phase 4
- Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled TrialCompletedNCT01225445Phase 3
- Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal InsufficiencyTerminatedNCT01223755Phase 2/3
- Influence of Aliskiren on ProteinuriaCompletedNCT01219413Phase 4
- Prevention of Contrast Renal Injury With Different Hydration StrategiesCompletedNCT01218828Phase 3